SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001564590-20-043651
Filing Date
2020-09-16
Accepted
2020-09-16 08:11:35
Documents
13
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A alvr-10qa_20200630.htm 10-Q/A 63232
2 EX-31.1 alvr-ex311_6.htm EX-31.1 9046
3 EX-31.2 alvr-ex312_7.htm EX-31.2 9087
  Complete submission text file 0001564590-20-043651.txt   221616

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT alvr-20200630.xml EX-101.INS 7554
5 XBRL TAXONOMY EXTENSION SCHEMA alvr-20200630.xsd EX-101.SCH 5776
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE alvr-20200630_lab.xml EX-101.LAB 26171
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alvr-20200630_pre.xml EX-101.PRE 15708
Mailing Address 139 MAIN STREET, SUITE 500 CAMBRIDGE MA 02142
Business Address 139 MAIN STREET, SUITE 500 CAMBRIDGE MA 02142 (617) 433-2605
Allovir, Inc. (Filer) CIK: 0001754068 (see all company filings)

IRS No.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-39409 | Film No.: 201177436
SIC: 2836 Biological Products, (No Diagnostic Substances)